No Detail Found!

Exploring the Expression Dynamics of Angiogenic Biomarkers in Breast Cancer: A Framework for Advanced Disease assessment and therapeutics

Author(s)
Hafsa Rasheed Kausar Abdullah Malik School of Life Sciences, Forman Christian College (A Chartered University), Lahore, Pakistan.
Kauser Bano Department of Medical Oncology, Allama Iqbal Medical College/Jinnah Hospital Lahore, Pakistan.
Zunera Tanveer Department of Physiology, Bolan Medical College, Quetta, Pakistan.
Adnan Arshad Kausar Abdullah Malik School of Life Sciences, Forman Christian College (A Chartered University), Lahore, Pakistan.
Abstract
Objective: The present study was conducted with the aim to determine plasma expression levels of angiogenic biomarkers including HIF-1a, VEGF-A, ANG-2, FGF-2 and uPA in peripheral blood in breast cancer patients to establish if they could be used as potential biomarkers for breast cancer advanced disease assessment is relation to clinicopathological association. Materials and Methods: Blood samples of 112 Breast cancer patients and 25 healthy females were obtained, their RNA was extracted, reversed transcribed into cDNA and then analyzed using RT-qPCR. A correlation was observed among angiogenic and metastatic factors according to classical clinical-pathological risk factors. Results: The plasma angiogenic (HIF-1, VEGF-A, ANG-2, FGF-2, and uPA) biomarkers levels were significantly elevated. Observed elevations were in significant association with well-known clinicopathological variables. Conclusion: Higher expression levels of suggest that these genes can be considered as major culprits in causing angiogenesis and metastasis. Being potential biomarkers, a gene signature can be developed for determining the severity of breast tumor; therefore, can be exploited as novel therapeutic approaches to block tumor metastasis and angiogenesis.
Publication Details
Page(s) 39-47
Published Journal: National Journal of Medical and Health Sciences, Volume: 5, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Expression profiling, Metastasis, angiogenesis, Breast Cancer, Therapeutics Biomarkers
References
Ali M.,Khaliq H. M. H.,Batool A.,Bano K.,Arshad A. .2023 .Assessing the Feasibility and Clinical Implications of multimarker RT-qPCR Profiling for Circulating Tumor Cell Detection in Breast Cancer Patients: A Pilot Study. National Journal of Medical and Health Sciences, 5(1) : 1-7.
Carmeliet P.,Jain R. K. .2011 .Molecular mechanisms and clinical applications of angiogenesis. Nature, 473(7347) : 298-307.
Han S.,Mallampalli R. K. .1950 .The acute respiratory distress syndrome: from mechanism to translation. Journal of immunology (Baltimore, 194(3) : 855-860.
Leung D. W.,Cachianes G.,Kuang W. J.,Goeddel D. V.,Ferrara N. .1989 .Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246(4935) : 1306-1309.
Li Y.,Zhang M. Z.,Sun S. J.,Zhou X.,Li C.,J. C.,Feng J.,Lu J.,Pei-Jun S. Y.,Wang L.,J. C. L. .2023 .HIF-1α inhibitor YC-1 suppresses triple-negative breast cancer growth and angiogenesis by targeting PlGF/VEGFR1-induced macrophage polarization. Biomedicine & pharmacotherapy = Biomedecine & Pharmacotherapie, 161 : 114423.
Madu C. O.,Wang S.,Madu C. O.,Lu Y. .2020 .Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment. Journal of Cancer, 11(15) : 4474-94.
Mendonsa A. M.,Na T. Y.,Gumbiner B. M. .2018 .E-cadherin in contact inhibition and cancer. Oncogene, 37(35) : 4769-4780.
Montemagno C.,Pagès G. .2020 .Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs. Frontiers in cell and developmental biology, 8 : 584.
Shahneh F. Z.,Baradaran B.,Zamani F.,Aghebati-Maleki L. .2013 .Tumor angiogenesis and anti-angiogenic therapies. Human antibodies, 22(1-2) : 15-19.
Oh S. Y.,Kwon H. C.,Kim S. H.,Jang J. S.,Kim M. C.,Kim J. Y.,Kim C. O.,Kim S. J.,Jeong J. S.,Kim H. J. .2008 .Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer. BMC cancer, 8 : 123.
Srabovic N.,Mujagic Z.,Mujanovic-Mustedanagic J.,Softic A.,Muminovic Z.,Rifatbegovic A.,Begic L. .2013 .Vascular endothelial growth factor receptor-1 expression in breast cancer and its correlation to vascular endothelial growth factor A. International journal of breast cancer, 746749 : .
Wang X.,Chen H.,X. H. .2019 .Drug resistance and combating drug resistance in cancer. Cancer drug resistance (Alhambra, Calif. , 2(2) : 141-160.
Xuan Z. X.,Zhang S.,Yuan S. J.,Wang W.,Yu J. .2016 .Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis. World journal of surgical oncology, 14(1) : 237.
0

Citations

0

Downloads

88

Views